Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00972478
Brief Title: Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

First Submitted : September 4, 2009
First Submitted that Met QC Criteria : September 4, 2009
First Posted : September 7, 2009 (Estimate)

Results First Submitted : September 8, 2016
Results First Submitted that Met QC Criteria : September 8, 2016
Results First Posted : October 31, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 4, 2021
Last Update Posted : August 6, 2021